Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Nuclear Medicine

  Free Subscription


29.08.2022

1 Ann Neurol
1 Ann Nucl Med
2 Clin Nucl Med
4 J Nucl Med
3 Nucl Med Commun
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. BACHMANN D, Roman ZJ, Buchmann A, Zuber I, et al
    Lifestyle Affects Amyloid Burden and Cognition Differently in Men and Women.
    Ann Neurol. 2022;92:451-463.
    PubMed         Abstract available


    Ann Nucl Med

  2. TELLI TA, Ozguven S, Alan O, Filizoglu N, et al
    Role of baseline (68)Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment.
    Ann Nucl Med. 2022 Aug 23. pii: 10.1007/s12149-022-01785.
    PubMed         Abstract available


    Clin Nucl Med

  3. QI J, Nguyen NC
    Potential Pitfall of Fluciclovine PET/CT in Castrate-Resistant Prostate Cancer With Adrenal Metastasis.
    Clin Nucl Med. 2022 Aug 26. pii: 00003072-990000000-00243.
    PubMed         Abstract available

  4. TOSUNOGLU Z, Erol Fenercioglu O, Beyhan E, Arslan E, et al
    Late-Term Findings of Pancreatitis on 68Ga-PSMA PET/CT in a Patient With Prostate Cancer.
    Clin Nucl Med. 2022 Aug 26. pii: 00003072-990000000-00242.
    PubMed         Abstract available


    J Nucl Med

  5. LAFOREST R, Ghai A, Fraum TJ, Oyama R, et al
    First-in-Human Evaluation of Safety and Dosimetry of (64)Cu-LLP2A for PET Imaging.
    J Nucl Med. 2022 Aug 25. pii: jnumed.122.264349. doi: 10.2967/jnumed.122.264349.
    PubMed         Abstract available

  6. PATHMANANDAVEL S, Crumbaker M, Ho B, Yam AO, et al
    Evaluation of (177)Lu-PSMA SPECT Quantitation as a Response Biomarker within a Prospective (177)Lu-PSMA-617 and NOX66 Combination Trial (LuPIN).
    J Nucl Med. 2022 Aug 25. pii: jnumed.122.264398. doi: 10.2967/jnumed.122.264398.
    PubMed         Abstract available

  7. SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Moscoso A, Scholl M, et al
    Differential effects of tau stage, Lewy body pathology, and substantia nigra degeneration on FDG-PET patterns in clinical AD.
    J Nucl Med. 2022 Aug 25. pii: jnumed.122.264213. doi: 10.2967/jnumed.122.264213.
    PubMed         Abstract available

  8. HAGENS MJ, Oprea-Lager DE, Vis AN, Wondergem M, et al
    Reproducibility of PSMA PET/CT Imaging for primary staging of treatment-naive prostate cancer patients depends on the applied radiotracer: a retrospective study.
    J Nucl Med. 2022 Aug 25. pii: jnumed.121.263139. doi: 10.2967/jnumed.121.263139.
    PubMed         Abstract available


    Nucl Med Commun

  9. GOKSEL S, Ilkkilic K, Bulbul O, Akdogan E, et al
    Relation of whole-body metabolic tumor volume and total lesion glycolysis on fluorodeoxyglucose PET/computed tomography with clinical and laboratory parameters in newly diagnosed multiple myeloma.
    Nucl Med Commun. 2022 Aug 26. pii: 00006231-990000000-00058.
    PubMed         Abstract available

  10. LIU Y, Hua J, Liu L, Zhang W, et al
    The value of the SUV ratio between lymph node and bone marrow in predicting pelvic lymphatic metastasis of patients with locally advanced cervical cancer: an integrated PET/CT study.
    Nucl Med Commun. 2022 Aug 25. pii: 00006231-990000000-00057.
    PubMed         Abstract available

  11. CHAUDHARY J, Pandey AK, Sharma PD, Jaleel J, et al
    Near-lossless compression of PET/CT images using singular value decomposition.
    Nucl Med Commun. 2022 Aug 22. pii: 00006231-990000000-00056.
    PubMed         Abstract available


    PLoS One

  12. SOMASUNDARAM A, Vallez Garcia D, Pfaehler E, van Sluis J, et al
    Mitigation of noise-induced bias of PET radiomic features.
    PLoS One. 2022;17:e0272643.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  13. MEDEL V, Crossley N, Gajardo I, Muller E, et al
    Whole-brain neuronal MCT2 lactate transporter expression links metabolism to human brain structure and function.
    Proc Natl Acad Sci U S A. 2022;119:e2204619119.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: